| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 9.33 Million |
| Market Size (2030) | USD 11.57 Million |
| CAGR (2025 - 2030) | 10.00 % |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Israel Electrocardiograph (ECG) Market Analysis
The Israel Electrocardiograph Market size is estimated at USD 9.33 million in 2025, and is expected to reach USD 11.57 million by 2030, at a CAGR of 10% during the forecast period (2025-2030).
The ECG market in Israel is experiencing significant growth, driven by the increasing prevalence of cardiovascular diseases, advancements in technology, and heightened awareness of heart health. Additionally, the ECG market in Israel is expected to expand due to the development of healthcare infrastructure and a growing focus on preventative care.
The rising incidence of cardiovascular diseases is fueling the demand for diagnostic tools such as ECG devices, which are essential for early detection and management of heart conditions. For instance, a study published in the Journal of American Heart Association in April 2024 revealed that nearly 20% of adults with congenital heart disease in Israel experienced abnormal heart rhythms over five years. This high incidence is driving the need for innovative ECG devices, which play a critical role in early diagnosis and effective management, thereby contributing to market growth.
Similarly, a report published in the Journal of Clinical Medicine in February 2024 highlighted changes in patient admissions during the 2023 period. The data showed that 94 out of 295 individuals were diagnosed with ST-segment elevation myocardial infarction (STEMI) in Israel between October 2023 and January 2024, compared to 63 out of 261 during the same period in the previous year. The increase in STEMI and arrhythmias during the conflict period underscores the urgent need for advanced cardiac monitoring solutions, emphasizing the importance of timely and accurate diagnosis. This trend is expected to drive the demand for ECG devices and is likely to drive market growth in the country over the forecast period.
Thus, the growing prevalence of cardiac conditions, combined with growing adoption of ECG devices, is anticipated to propel market growth during the forecast period. However, the high costs associated with advanced ECG devices act as a constraint, potentially limiting the market's expansion in Israel during the same timeframe.
Israel Electrocardiograph (ECG) Market Trends
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
Israel's Holter ECG systems segment is experiencing robust growth, driven by the integration of artificial intelligence and machine learning into these devices. This growth is further supported by increasing awareness of the critical need for early detection and prevention of cardiovascular diseases. These advancements highlight the segment's essential role in meeting the rising demand for accurate and efficient diagnostic tools within the broader ECG market.
Israel's aging population is increasingly prone to cardiovascular conditions, which is expected to drive the demand for ECG devices. The elderly demographic requires consistent cardiac monitoring, presenting a significant market opportunity. For instance, according to data from Israel's Central Bureau of Statistics, published in August 2023, approximately 12% of the country's population were aged 65 and above. Projections estimate this figure will rise to 14% of the total population by 2030. Additionally, the population aged 75 and over is expected to see a 48% increase, reaching approximately 740,000 by 2030. These statistics emphasize the growing need for healthcare solutions, particularly advanced diagnostic tools like Holter ECG devices, tailored to the elderly's requirements. This trend is anticipated to foster further innovation and adoption of these holter ECG technologies in Israel.
Additionally, the the integration of advanced technologies, such as artificial intelligence, into Holter ECG devices is increasing in the market. Ventricular tachycardia (VT), a severe cardiac arrhythmia with the potential to cause sudden cardiac death, underscores the importance of early detection and management, propelling the demand for advanced holter ECG systems in the market. For instance, a study published in the European Heart Journal - Digital Health, in July 2024, demonstrated AI's capability to detect ECG changes associated with arrhythmias. Conducted at Rambam Hospital's Holter Clinic in Israel, the research utilized a continuous 24-hour Holter electrocardiogram to identify patients with VT during sinus rhythm. This study not only showcased AI's potential to enhance diagnostic accuracy but also validated the feasibility of long-term ECG monitoring. These advancements highlight the rapid adoption of innovative Holter ECG solutions, driving segment growth.
Thus, the convergence of demographic trends, technological advancements, and the growing focus on early detection of cardiovascular conditions is significantly propelling the growth of Holter ECG devices in Israel.
Understand The Key Trends Shaping This Market
Download PDF
ECG Management Software is Expected to Have Fastest Growth in the Market Over the Forecast Period
ECG management software optimizes the workflow of electrocardiogram (ECG) tests, encompassing data acquisition, analysis, storage, and retrieval. By utilizing advanced algorithms and artificial intelligence, this software enhances the efficiency and precision of cardiac care, enabling the interpretation of ECG data, detection of abnormalities, and delivery of diagnostic insights. Additionally, it integrates seamlessly with electronic health records (EHR), providing healthcare providers with comprehensive patient information and supporting improved clinical decision-making.
ECG management software is critical for continuous monitoring and accurate diagnostics, which are essential for the early detection and management of heart conditions. The ECG management software market in Israel is experiencing growth, driven by factors such as the increasing prevalence of cardiovascular diseases, particularly among the aging population, and advancements in technology, including improved data integration capabilities. The expansion of telemedicine and remote patient monitoring has further fueled the demand for ECG management software that supports remote diagnostics and continuous monitoring.
Additionally, supportive government policies and increased investments in healthcare infrastructure are fostering the adoption of advanced ECG management systems in Israel. For instance, in December 2023, the Ministry of Health allocated an additional NIS 1.4 billion (USD 392 million) to enhance hospitals and healthcare organizations. This funding focused on upgrading medical equipment, including ECG devices and management software, ensuring access to advanced technologies. The budget also supported integrating ECG data with electronic health records (EHR), streamlining data management and improving clinical workflows. These measures are expected to fuel the growth of the ECG management software segment by increasing adoption and enhancing healthcare system efficiency.
Thus, the combination of technological advancements, growing demand for remote monitoring, supportive government initiatives, and substantial investments in healthcare infrastructure is driving the adoption of ECG management software. These factors collectively improve healthcare system efficiency, ultimately fueling the growth of the ECG management software segment over the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
Israel Electrocardiograph (ECG) Industry Overview
The competitive landscape of Israel's electrocardiograph (ECG) market features a combination of well-established companies and emerging players. The market is semi-consolidated yet remains competitive. Additionally, numerous companies provide specialized solutions, fostering a dynamic and evolving ecosystem. Some of the key companies in the market include Norav Medical, GE Healthcare, Nihon Kohden Corporation, Koninklijke Philips N.V., and Contec Medical Systems Co., Ltd., among others.
Israel Electrocardiograph (ECG) Market Leaders
-
Norav Medical
-
Nihon Kohden Corporation
-
Koninklijke Philips N.V.
-
GE Healthcare
-
Contec Medical Systems Co., Ltd.
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Israel Electrocardiograph (ECG) Market News
- September 2024: The World Heart Federation spearheaded a global petition, calling on nations worldwide, Israel included, to adopt a 'National Cardiovascular Action Plan' in a bid to combat heart disease. This move seeks to champion holistic approaches to both the prevention and management of heart ailments. Such action plans will likely prioritize the integration of advanced diagnostic tools, such as ECG devices, for heart disease management, bolstering market growth over the forecast period.
- June 2024: The Tel Aviv Expo Convention Center held a conference focusing on the latest medical innovations and technological advancements, featuring sessions specifically dedicated to raising awareness about heart disease and its prevention. Such initiatives are expected to drive the growth of ECG devices in the market by increasing awareness and demand for early diagnosis and monitoring solutions.
Israel Electrocardiograph (ECG) Industry Segmentation
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The Israel electrocardiograph (ECG) market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The Israel electrocardiograph (ECG) market is segmented by product type, which includes resting ECG systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
| By Product Type | Resting ECG Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software |
Need A Different Region or Segment?
Customize Now
Israel Electrocardiograph (ECG) Market Research FAQs
How big is the Israel Electrocardiograph Market?
The Israel Electrocardiograph Market size is expected to reach USD 9.33 million in 2025 and grow at a CAGR of 10% to reach USD 11.57 million by 2030.
What is the current Israel Electrocardiograph Market size?
In 2025, the Israel Electrocardiograph Market size is expected to reach USD 9.33 million.
Who are the key players in Israel Electrocardiograph Market?
Norav Medical, Nihon Kohden Corporation, Koninklijke Philips N.V., GE Healthcare and Contec Medical Systems Co., Ltd. are the major companies operating in the Israel Electrocardiograph Market.
What years does this Israel Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the Israel Electrocardiograph Market size was estimated at USD 8.40 million. The report covers the Israel Electrocardiograph Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Israel Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Israel Electrocardiograph (ECG) Industry Report
Statistics for the 2025 Israel Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Israel Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
